In 2023, Austria led with 129.7 hospital discharges per hundred thousand persons for malignant neoplasm of the uterus, followed by the Czech Republic at 107.6. Germany and Slovakia also had high values, 91.5 and 101.1, respectively. Conversely, Spain, Portugal, Australia, Ireland, and Israel recorded significantly lower numbers, under 42 discharges per hundred thousand persons.
Year-on-year variations in 2023 highlighted significant growth in the Czech Republic at 10.5%, while minor declines were observed in Austria, Slovakia, Germany, and Ireland. Other countries experienced slight positive trends.
Future trends to watch include potential increases in early detection, which might lead to higher initial discharge rates followed by a decline, and technological advancements in treatment reducing the length of hospital stays.
Top countries in Hospital Discharges for Malignant Neoplasm of Uterus by Country
| # | 9 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Austria | 129.7 | 2023 | +2.13% | -0.89% | View data |
| 2 | 2 Czech Republic | 107.6 | 2023 | +10.81% | +10.5% | View data |
| 3 | 3 Slovakia | 101.1 | 2023 | -0.79% | -2.37% | View data |
| 4 | 4 Germany | 91.5 | 2023 | -0.54% | -0.87% | View data |
| 5 | 5 Spain | 41.4 | 2023 | +0.24% | +0.24% | View data |
| 6 | 6 Portugal | 40.4 | 2021 | +7.73% | View data | |
| 7 | 7 Australia | 38 | 2023 | +0.26% | +0.43% | View data |
| 8 | 8 Ireland | 36.1 | 2023 | +4.64% | -1.78% | View data |
| 9 | 9 Israel | 30.9 | 2023 | -0.96% | +0.86% | View data |
